Recent study on combination therapy ChondroFiller® collagen plus stem cells
As part of a recent study, 25 individuals with advanced knee osteoarthritis were treated with a regenerative therapy. Some participants received a pure stem cell injection, while a second group was additionally given a cell-free collagen matrix known as ChondroFiller®. The aim was to determine whether this combination therapy could produce better results than stem cells alone.
The outcome was clear: patients who received the collagen matrix reported significantly less pain, improved mobility, and an overall higher quality of life. Imaging techniques such as MRI scans also showed a reduction in inflammation and swelling in the affected knee joint—strong evidence of the treatment’s regenerative potential.
The significance of this development is considerable. Millions of people worldwide suffer from knee osteoarthritis, a condition often associated with chronic pain and limited movement. Until now, joint replacement surgery has often been considered the final option. However, this new therapy could change that: by harnessing the regenerative power of stem cells, the joint can be strengthened and its natural function maintained over the long term.
Equally encouraging is the treatment’s excellent safety profile. No serious side effects were observed during the study—an important factor for patients seeking to avoid invasive surgery or prolonged pain medication. The promising results from Vienna therefore offer genuine hope that the future of osteoarthritis treatment could be far more gentle and effective.
